Drug intelligence / Profile preview

TONKA

Development stage: Phase 3
Lead developer: Nhat Nhat Pharmaceutical
Administration: Oral

Overview

TONKA is a multi-ingredient herbal medicine developed by Nhat Nhat Pharmaceutical Company. It is composed of traditional Vietnamese herbs including White Peony (Bạch thược), Atractylodes macrocephala (Bạch truật), Licorice (Cam thảo), Phyllanthus urinaria (Diệp hạ châu), Codonopsis pilosula (Đảng sâm), Angelica sinensis (Đương quy), Artemisia capillaris (Nhân trần), Poria (Phục linh), and Citrus reticulata (Trần bì). TONKA is being investigated in a Phase IIIb clinical trial for its efficacy in lowering elevated hepatic enzymes (ALT and AST) in patients with moderate to severe liver function disorders. It is administered orally and aims to support liver health, promote detoxification, and regenerate liver cells, addressing symptoms associated with various liver conditions.

Brand names: TONKA Nhất Nhất

Beyond the preview

Go deeper on TONKA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TONKA.

Explore the full profile